Urol. praxi. 2020;21(3):119-121 | DOI: 10.36290/uro.2020.012
Prostate rebiopsy: when should be performed?
- Urologická klinika VFN a 1. LF UK v Praze
Prostate rebiopsy is indicated in case of the permanently elevated or increasing level of prostate specific antigen (PSA). Other indications include low free to total PSA ratio or high Prostate Health Index (phi). Histological parameters for the indication of rebiopsy include atypical small acinar proliferation (ASAP), high-grade prostatic intraepithelial neoplasia (HG-PIN) in more than two biopsy cores specimens, small atypical glands associated with HG-PIN (PINATYP) or intraductal carcinoma. Multi-parametric magnetic resonance imaging is used mainly in the repeat prostate biopsy because it can more often detect significant prostate cancer compared to standard biopsy.
Keywords: prostate rebiopsy, atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, multi-parametric magnetic resonance imaging of the prostate.
Received: March 20, 2020; Revised: March 20, 2020; Accepted: March 20, 2020; Prepublished online: March 20, 2020; Published: October 16, 2020 Show citation
References
- Ankerst DP, Thompson IM. Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification. Arch Ital Urol Androl 2006; 78(4): 125-129.
- https://uroweb.org/guideline/prostate-cancer/#5. Přístup 8. 3. 2020.
- Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998; 279(19): 1542-1547.
Go to original source... 
Go to PubMed... - Kaplan SA, Ghafar MA, Volpe MA, et al. PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study. Urology 2002; 60(3): 464-468. Go to original source... Go to PubMed...
- Catalona WJ, Partin AW, Sanda MG, et al. A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. J Urol 2011; 185(5): 1650-1655. Go to original source... Go to PubMed...
- Ericson KJ, Wenger HC, Rosen AM, et al. Prostate cancer detection following diagnosis of atypical small acinar proliferation. Can J Urol 2017; 24(2): 8714-8720.
- Merrimen JL, Jones G, Walker D, et al. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol 2009; 182(2): 485-490. Go to original source... Go to PubMed...
- Kronz JD, Shaikh AA, Epstein JI. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy. Hum Pathol 2001; 32(4): 389-395. Go to original source...
- Kimura K, Tsuzuki T, Kato M, et al. Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens. Prostate 2014; 74(6): 680-687. Go to original source... Go to PubMed...
- Simmons LAM, Kanthabalan A, Arya M, et al. The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy. Br J Cancer 2017; 116(9): 1159-1165. Go to original source... Go to PubMed...
- Drost FH, Osses D, Nieboer D, et al. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis. Eur Urol 2020; 77(1): 78-94. Go to original source... Go to PubMed...